Behavioral and pharmacological responses of selectively bred and inbre
d rodent lines have been analyzed to elucidate many features of drug s
ensitivity and the adverse effects of drugs, the underlying mechanisms
of drug tolerance and dependence, and the motivational states underly
ing drug reward and aversion. Genetic mapping of quantitative trait lo
ci (QTLs) has been used to identify provisional chromosomal locations
of genes influencing such pharmacological responses. Recent advances i
n transgenic technology, representational difference analysis, and oth
er molecular methods now make feasible the positional cloning of QTLs
that influence sensitivity to drugs of abuse. This marks a new period
of synthesis in pharmacogenetic research, in which networks of drug-re
lated behaviors, their underlying pharmacological, physiological, and
biochemical mechanisms, and particular genomic regions of interest are
being identified.